3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Breast Diseases
1
Interventions
Fulvestrant
26
Letrozole
25
Specimen Handling
19
ribociclib
18
Capecitabine
16
pembrolizumab
15
palbociclib
13
Trastuzumab
13
Paclitaxel
13
abemaciclib
12
Tamoxifen
12
Anastrozole
12
exemestane
11
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
10
Carboplatin
10
Biopsy
9
pertuzumab
8
Goserelin
8
inavolisib
6
Standard of Care
6
Cyclophosphamide
6
olaparib
5
giredestrant
5
elacestrant
5
Taxes
5
Radiotherapy
5
Radiation
5
130-nm albumin-bound paclitaxel
5
pyrotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Body Height
×
30 days
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled